Example risk assessment for proposed activities involving; Gene Therapy Medicinal Products (GTMPs) or Gene Therapy Investigational Medicinal Products (GTIMPs) Kamilah Lakhani-Powell2023-02-22T16:19:27+00:0024th August 2021| An example risk assessment used to fully review the risk posed by GTMP/GTiMPs in preparation for submission to local genetic modification safety committee Related Posts London Advanced Therapies ATTC joins the Network! 19th Sep 2024 £17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK 21st Mar 2024 Recommendations for Gene Therapy Patient Referrals 11th Mar 2024
